As of June 2024 SurgePays has a market cap of $71.04 Million. This makes SurgePays the world's 7630th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $71.04 M | -22.58% |
2023 | $91.77 M | 11.64% |
2022 | $82.2 M | 237.33% |
2021 | $24.36 M | 63.13% |
2020 | $14.93 M | -51.28% |
2019 | $30.65 M | -8.37% |
2018 | $33.45 M | -49.57% |
2017 | $66.34 M | 333.75% |
2016 | $15.29 M | -5.92% |
2015 | $16.25 M | 7443.06% |
2014 | $0.21 M | 42.86% |
2013 | $0.15 M | |
2011 | $1.07 M | 55.06% |
2010 | $0.69 M | -27.85% |
2009 | $0.96 M | -93.92% |
2008 | $15.84 M |
On May 31st, 2024 the market cap of SurgePays was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $352.98 B | 496,740.79% | ๐บ๐ธ USA |
Novartis NVS | $210.42 B | 296,082.93% | ๐จ๐ญ Switzerland |
Stryker Corporation SYK | $129.93 B | 182,791.94% | ๐บ๐ธ USA |
Cooper Companies COO | $18.74 B | 26,283.69% | ๐บ๐ธ USA |
STAAR Surgical STAA | $2.04 B | 2,771.94% | ๐บ๐ธ USA |
CONMED CNMD | $2.35 B | 3,213.90% | ๐บ๐ธ USA |
Integra LifeSciences IART | $2.43 B | 3,327.21% | ๐บ๐ธ USA |